Skip to main content
Erschienen in: International Urogynecology Journal 7/2022

02.07.2021 | Original Article

Hysteropreservation versus hysterectomy in uterine prolapse surgery: a systematic review and meta-analysis

verfasst von: Li He, Dan Feng, Xi Zha, Xiao-Yan Liao, Zhao-Lin Gong, Ding-Qian Gu, Yong-Hong Lin, Lu Huang

Erschienen in: International Urogynecology Journal | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Hysteropreservation and hysterectomy for uterine prolapse have been compared in several randomized controlled trials (RCTs), as the best treatment has not been definitively determined. This study aimed to summarize the available evidence in RCTs of hysteropreservation versus hysterectomy.

Methods

We performed electronic searches in the PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure databases for eligible RCTs from inception to June 2020. The relative risks (RRs) and weighted mean differences (WMDs) with corresponding 95% confidence intervals (CIs) were calculated for categorical and continuous variables using random-effects models.

Results

Twelve RCTs involving 1177 patients were selected for meta-analysis. There were no significant differences between hysteropreservation and hysterectomy for the incidences of recurrence (RR, 0.55; 95% CI, 0.26–1.19; P = 0.130) and reoperation (RR, 1.15; 95% CI, 0.56–2.37; P = 0.705). Moreover, neither hysteropreservation nor hysterectomy had any significant effect on the risk of constipation (RR, 0.72; 95% CI, 0.15–3.46; P = 0.681), voiding dysfunction (RR, 0.99; 95% CI, 0.54–1.84; P = 0.981), intraoperative bleeding (RR, 0.35; 95% CI, 0.05–2.26; P = 0.271), upper leg dullness (RR, 0.70; 95% CI, 0.15–3.17; P = 0.643), dyspareunia (RR, 1.47; 95% CI, 0.69–3.13; P = 0.317), and wound infection (RR, 1.38; 95% CI, 0.24–7.80; P = 0.714). Furthermore, hysteropreservation was associated with less intraoperative blood loss (WMD, −25.68; 95% CI, −44.39 to −6.96; P = 0.007), shorter duration of surgery (WMD, −11.30; 95% CI, −19.04 to −3.55; P = 0.004), and shorter duration of hospitalization (WMD, −0.63; 95% CI, −1.10 to −0.16; P = 0.009) compared with hysterectomy.

Conclusion

This study found that both hysteropreservation and hysterectomy have similar effects on recurrence and reoperation rates, while hysteropreservation was superior to hysterectomy in reducing intraoperative blood loss and shortening the duration of surgery and hospitalization.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369:1027–38.CrossRef Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369:1027–38.CrossRef
2.
Zurück zum Zitat Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2013;24:1783–90.CrossRef Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2013;24:1783–90.CrossRef
3.
Zurück zum Zitat Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Neurourol Urodyn. 2016;35:137–68.CrossRef Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Neurourol Urodyn. 2016;35:137–68.CrossRef
4.
Zurück zum Zitat De Boer TA, Slieker-ten Hove MC, Burger CW, Kluivers KB, Vierhout ME. The prevalence and factors associated with previous surgery for pelvic organ prolapse and or urinary incontinence in a cross sectional study in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;158:343–9.CrossRef De Boer TA, Slieker-ten Hove MC, Burger CW, Kluivers KB, Vierhout ME. The prevalence and factors associated with previous surgery for pelvic organ prolapse and or urinary incontinence in a cross sectional study in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;158:343–9.CrossRef
5.
Zurück zum Zitat Vanspauwen R, Seman E, Dwyer P. Survey of current management of prolapse in Australia and New Zealand. Aust N Z J Obstet Gynaecol. 2010;50:262–7.CrossRef Vanspauwen R, Seman E, Dwyer P. Survey of current management of prolapse in Australia and New Zealand. Aust N Z J Obstet Gynaecol. 2010;50:262–7.CrossRef
6.
Zurück zum Zitat Meriwether KV, Antosh DD, Olivera CK, et al. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. Am J Obstet Gynecol. 2018;219:129–146.e2.CrossRef Meriwether KV, Antosh DD, Olivera CK, et al. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. Am J Obstet Gynecol. 2018;219:129–146.e2.CrossRef
7.
Zurück zum Zitat Korbly NB, Kassis NC, Good MM, et al. Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol. 2013;209:470.e1–6.CrossRef Korbly NB, Kassis NC, Good MM, et al. Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol. 2013;209:470.e1–6.CrossRef
8.
Zurück zum Zitat Dällenbach P, Kaelin-Gambirasio I, Jacob S, Dubuisson JB, Boulvain M. Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1623–9.CrossRef Dällenbach P, Kaelin-Gambirasio I, Jacob S, Dubuisson JB, Boulvain M. Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1623–9.CrossRef
9.
Zurück zum Zitat Brummen HJ, van de Pol G, Aalders CIM, Heintz APM, van der Vaart CH. Sacrospinous hysteropexy compared to vaginal hysterectomy as primary surgical treatment for a descensus uteri: effect on urinary symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:350–5.CrossRef Brummen HJ, van de Pol G, Aalders CIM, Heintz APM, van der Vaart CH. Sacrospinous hysteropexy compared to vaginal hysterectomy as primary surgical treatment for a descensus uteri: effect on urinary symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:350–5.CrossRef
10.
Zurück zum Zitat Gutman RE, Rardin CR, Sokol ER, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216:38.e1–38.e11.CrossRef Gutman RE, Rardin CR, Sokol ER, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216:38.e1–38.e11.CrossRef
11.
Zurück zum Zitat Roovers JP, van der Vaart CH, van der Bom JG, et al. A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function. BJOG. 2004;111:50–6.CrossRef Roovers JP, van der Vaart CH, van der Bom JG, et al. A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function. BJOG. 2004;111:50–6.CrossRef
12.
Zurück zum Zitat Carramão S, Auge AP, Pacetta AM, et al. Estudo randômico da correção cirúrgica do prolapso uterino através de tela sintética de polipropileno tipo I comparando histerectomia versus preservação uterina [A randomized comparison of two vaginal procedures for the treatment of uterine prolapse using polypropylene mesh: hysteropexy versus hysterectomy]. Rev Col Bras Cir. 2009;36:65–72.CrossRef Carramão S, Auge AP, Pacetta AM, et al. Estudo randômico da correção cirúrgica do prolapso uterino através de tela sintética de polipropileno tipo I comparando histerectomia versus preservação uterina [A randomized comparison of two vaginal procedures for the treatment of uterine prolapse using polypropylene mesh: hysteropexy versus hysterectomy]. Rev Col Bras Cir. 2009;36:65–72.CrossRef
13.
Zurück zum Zitat Dietz V, van der Vaart CH, van der Graaf Y, Heintz P, Schraffordt Koops SE. One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine descent: a randomized study. Int Urogynecol J. 2010;21:209–16.CrossRef Dietz V, van der Vaart CH, van der Graaf Y, Heintz P, Schraffordt Koops SE. One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine descent: a randomized study. Int Urogynecol J. 2010;21:209–16.CrossRef
14.
Zurück zum Zitat Qiao H. Comparison of the effect of pelvic floor reconstruction with vaginal hysterectomy for uterine prolapse. Clin Med. 2015;35:95–6. Qiao H. Comparison of the effect of pelvic floor reconstruction with vaginal hysterectomy for uterine prolapse. Clin Med. 2015;35:95–6.
15.
Zurück zum Zitat Rahmanou P, Price N, Jackson SR. Laparoscopic hysteropexy versus vaginal hysterectomy for the treatment of uterovaginal prolapse: a prospective randomized pilot study. Int Urogynecol J. 2015;26:1687–94.CrossRef Rahmanou P, Price N, Jackson SR. Laparoscopic hysteropexy versus vaginal hysterectomy for the treatment of uterovaginal prolapse: a prospective randomized pilot study. Int Urogynecol J. 2015;26:1687–94.CrossRef
16.
Zurück zum Zitat Detollenaere RJ, den Boon J, Stekelenburg J, et al. Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial. BMJ. 2015;351:h3717.CrossRef Detollenaere RJ, den Boon J, Stekelenburg J, et al. Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial. BMJ. 2015;351:h3717.CrossRef
17.
Zurück zum Zitat Song L. Observation on the curative effect of pelvic floor reconstruction with improved uterus preservation in the treatment of pelvic organ prolapse. Chin J Mod Drug Appl. 2016;10:102–3. Song L. Observation on the curative effect of pelvic floor reconstruction with improved uterus preservation in the treatment of pelvic organ prolapse. Chin J Mod Drug Appl. 2016;10:102–3.
18.
Zurück zum Zitat Rao H. Comparative study of pelvic floor reconstruction with preservation of uterus and vaginal hysterectomy for uterine prolapse. Contemp Med. 2016;22:58–9. Rao H. Comparative study of pelvic floor reconstruction with preservation of uterus and vaginal hysterectomy for uterine prolapse. Contemp Med. 2016;22:58–9.
19.
Zurück zum Zitat Xie H, Zhao F, Huang H. The application of laparoscopic uterine vaginal sacral fixation in the treatment of pelvic organ prolapse. Contemp Med. 2017;23:29–31. Xie H, Zhao F, Huang H. The application of laparoscopic uterine vaginal sacral fixation in the treatment of pelvic organ prolapse. Contemp Med. 2017;23:29–31.
20.
Zurück zum Zitat Nager CW, Visco AG, Richter HE, et al. Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: a randomized clinical trial. JAMA. 2019;322:1054–65.CrossRef Nager CW, Visco AG, Richter HE, et al. Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: a randomized clinical trial. JAMA. 2019;322:1054–65.CrossRef
21.
Zurück zum Zitat He Z. Comparative study of pelvic floor reconstruction with preservation of uterus and vaginal hysterectomy for uterine prolapse. Women Heal Res. 2019;6:35–7. He Z. Comparative study of pelvic floor reconstruction with preservation of uterus and vaginal hysterectomy for uterine prolapse. Women Heal Res. 2019;6:35–7.
22.
Zurück zum Zitat Qin H. Clinical effect of modified traditional uterine prolapse surgery in the treatment of uterine prolapse. Electron J Pract Gynecol Endocrinol. 2019;6:17–9. Qin H. Clinical effect of modified traditional uterine prolapse surgery in the treatment of uterine prolapse. Electron J Pract Gynecol Endocrinol. 2019;6:17–9.
23.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRef
24.
Zurück zum Zitat Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration; 2011. www.cochrane-handbook.org. Accessed 10 Jul 2020. Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration; 2011. www.​cochrane-handbook.​org. Accessed 10 Jul 2020.
25.
Zurück zum Zitat Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Mak. 2005;25:646–54.CrossRef Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Mak. 2005;25:646–54.CrossRef
26.
Zurück zum Zitat Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRef Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRef
27.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRef Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRef
28.
Zurück zum Zitat Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRef Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRef
29.
Zurück zum Zitat de Oliveira SA, Fonseca MCM, Bortolini MAT, Girão MJBC, Roque MT, Castro RA. Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis. Int Urogynecol J. 2017;28:1617–30.CrossRef de Oliveira SA, Fonseca MCM, Bortolini MAT, Girão MJBC, Roque MT, Castro RA. Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis. Int Urogynecol J. 2017;28:1617–30.CrossRef
Metadaten
Titel
Hysteropreservation versus hysterectomy in uterine prolapse surgery: a systematic review and meta-analysis
verfasst von
Li He
Dan Feng
Xi Zha
Xiao-Yan Liao
Zhao-Lin Gong
Ding-Qian Gu
Yong-Hong Lin
Lu Huang
Publikationsdatum
02.07.2021
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 7/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-021-04913-9

Weitere Artikel der Ausgabe 7/2022

International Urogynecology Journal 7/2022 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.